FDA
approval
· 2026-03-04
FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
Summary
FDA approved a supplemental application for Desipramine hydrochloride by Amneal Pharmaceuticals NY LLC, authorizing the generic product (ANDA 208105).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DESIPRAMINE HYDROCHLORIDE (DESIPRAMINE)